Tesamorelin + Ipamorelin 8mg Blend
CAS: 901758-09-6 / 170851-70-4
Tesamorelin + Ipamorelin 8mg Blend by Bio-Peptides is a high-purity research peptide formulation designed for laboratory studies of growth hormone (GH) axis signaling, endocrine communication, and receptor-selective peptide interactions. The formulation combines a synthetic GHRH analog (Tesamorelin) with a selective ghrelin-receptor agonist (Ipamorelin) to enable multi-pathway GH signaling research in controlled experimental environments.
$245.00
Research Use Only
Research Overview
Tesamorelin + Ipamorelin is a dual-peptide research blend designed for laboratory investigation of growth hormone axis signaling and endocrine communication pathways.
The combination integrates GHRH-mediated signaling through Tesamorelin with ghrelin receptor activation through Ipamorelin.
Researchers use this formulation to study coordinated GH release mechanisms, receptor cross-talk, and peptide synergy within hypothalamic–pituitary signaling models.
The dual-peptide design allows controlled experimental evaluation of endocrine pathway integration and hormone regulatory mechanisms.
Scientific Background
Growth hormone secretion is regulated by complex signaling interactions between hypothalamic GHRH stimulation and ghrelin-mediated receptor activation.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone used in research examining pituitary GH signaling.
Ipamorelin is a selective growth hormone secretagogue that interacts with the ghrelin receptor (GHS-R).
Combining these peptides enables researchers to examine complementary GH stimulation pathways within endocrine research models.
Mechanistic Research Perspective
- Growth hormone–releasing hormone receptor signaling studies
- Selective ghrelin receptor activation research
- Dual-pathway GH axis signaling analysis
- Peptide-receptor interaction investigation
- Endocrine feedback regulation research
Primary Research Applications
Growth Hormone Axis Research: Used in laboratory models investigating GH secretion dynamics and hormone regulatory pathways.
Endocrine Signaling Studies: Researchers analyze hypothalamic–pituitary communication and hormonal feedback loops.
Receptor Interaction Research: Applied in assays examining GHRH receptor signaling and ghrelin receptor activation.
Peptide Synergy Studies: Supports experimental models investigating coordinated peptide signaling behavior.
Comparative GH Peptide Research: Allows comparison between single-peptide and dual-peptide GH stimulation systems.
Molecular Characteristics
- Compound Name: Tesamorelin + Ipamorelin Blend
- Tesamorelin CAS Number: 901758-09-6
- Ipamorelin CAS Number: 170851-70-4
- Peptide Class: Growth hormone axis research peptides
- Form: Lyophilized peptide powder blend
- Unit Size: 8 mg research blend
Stability Profile and Storage Recommendations
- Store lyophilized peptide blend at −20°C
- Protect from moisture and light exposure
- Avoid repeated freeze–thaw cycles
- Reconstitute with sterile laboratory-grade solvent
- Maintain sealed storage after each use
Handling and Research Preparation Considerations
- Compatible with sterile aqueous research solvents
- Suitable for in-vitro endocrine signaling experiments
- Applicable in receptor activation assays
- Compatible with molecular biology peptide research workflows
- Designed for reproducible experimental preparation
Technical Specifications
product Name
Tesamorelin + Ipamorelin 8mg Blend
brand
BioPeptides
purity
Research-grade analytical quality
form
Lyophilized peptide powder blend
synthesis
Solid-phase peptide synthesis (SPPS)
analytical
Identity verification and purity testing
molecular Structure
Dual-peptide GH signaling formulation
stability
Stable under −20°C storage conditions
Analytical Validation and Quality Assurance
- Molecular identity verification for both peptides
- Purity and stability assessment
- Structural integrity analysis
- Batch-to-batch consistency validation
- Analytical quality control inspection
Frequently Asked Questions
The blend is used in laboratory studies examining growth hormone axis signaling, endocrine pathway interactions, and receptor-mediated peptide communication.
Combining these peptides allows researchers to examine both GHRH-mediated and ghrelin-receptor-mediated GH stimulation pathways within a single experimental model.
Yes. The blend is commonly used in controlled laboratory experiments studying receptor activation and hormone-related intracellular signaling.
This blend is used in endocrinology research, molecular biology studies, peptide signaling investigations, and hormone pathway analysis.
The 8mg format supports extended experimental protocols while reducing variability from sourcing peptides separately.
The blend should be stored at −20°C and protected from light and moisture.